Cargando…

Mesothelioma: Hippo pathway as a target, lessons from COMMAND

Detalles Bibliográficos
Autores principales:	Fennell, Dean A., Baitei, Essa Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956825/ https://www.ncbi.nlm.nih.gov/pubmed/31976036 http://dx.doi.org/10.18632/oncotarget.27018

Ejemplares similares

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Special Issue on “Disease and the Hippo Pathway”
por: Hansen, Carsten Gram
Publicado: (2019)

A Solomonesque Command
Publicado: (1900)

The Hippo pathway and cancer immunity: friend or foe?
por: Janse van Rensburg, Helena J, et al.
Publicado: (2018)

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
por: Fujii, Makiko, et al.
Publicado: (2012)

On the Move: The Commander IL-4 Leads the Cell Army in Collective Migration
por: Cheong, Sek-Shir, et al.
Publicado: (2019)

MicroRNAs as Commanders-in-Chief
por: Sáenz, José B.
Publicado: (2019)

Upstream regulators of the Hippo pathway
por: Yu, Fa-Xing, et al.
Publicado: (2012)

Precision Therapy for Mesothelioma: Feasibility and New Opportunities
por: Dulloo, Sean, et al.
Publicado: (2021)

Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
por: Zhang, Min, et al.
Publicado: (2021)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

The Courage to Take Command: Leadership Lessons from a Military Trailblazer
por: Morgenthaler, Jill
Publicado: (2014)

Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
por: Zhang, Min, et al.
Publicado: (2021)

Hippo Signaling in Cancer: Lessons From Drosophila Models
por: Snigdha, Kirti, et al.
Publicado: (2019)

Drugging the Hippo (Pathway): A Strategy to Stimulate Cardiac Regeneration?
por: Mani, Kartik, et al.
Publicado: (2018)

Lessons from Jonathan Mann: The Ten Commandments on Multidrug-Resistant TB
por: Kirby, Michael
Publicado: (2016)

Mesothelioma
por: Deraco, Marcello
Publicado: (2021)

Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018)

Ten simple rules for getting started with command-line bioinformatics
por: Brandies, Parice A., et al.
Publicado: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: Harber, James, et al.
Publicado: (2021)

Sensory Activation of Command Cells for Locomotion and Modulatory Mechanisms: Lessons from Lampreys
por: Daghfous, Gheylen, et al.
Publicado: (2016)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Sound the Alarmin: Interleukin-33 Commandeers the Gastric Immune Response
por: Noto, Jennifer M., et al.
Publicado: (2015)

New Therapeutic Approach for Targeting Hippo Signalling Pathway
por: Dominguez-Berrocal, Leticia, et al.
Publicado: (2019)

Targeting the Hippo Pathway in Prostate Cancer: What’s New?
por: Coffey, Kelly
Publicado: (2021)

The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023)

Solutions for commandeered journals, debatable journals, and forged journals
por: Jalalian, Mehrdad
Publicado: (2015)

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers: Hippo pathway: from multiple signals to the hallmarks of cancers
por: Zhu, Ning, et al.
Publicado: (2023)

Hippo signaling: Special issue of BMB Reports in 2018
por: Jho, Eek-hoon
Publicado: (2018)

The Hippo pathway as a target of the Drosophila DRE/DREF transcriptional regulatory pathway
por: Vo, Nicole, et al.
Publicado: (2014)

Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
por: Juan, Wen Chun, et al.
Publicado: (2016)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

The Hippo Pathway in Prostate Cancer
por: Salem, Omar, et al.
Publicado: (2019)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Mechanisms of Hippo pathway regulation
por: Meng, Zhipeng, et al.
Publicado: (2016)

The Hippo Pathway: Immunity and Cancer
por: Taha, Zaid, et al.
Publicado: (2018)

The Hippo Pathway and Viral Infections
por: Wang, Zhilong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s2bglmst4vhkarmp3e9paoqi8l